1. Home
  2. ADMA vs GFF Comparison

ADMA vs GFF Comparison

Compare ADMA & GFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • GFF
  • Stock Information
  • Founded
  • ADMA 2004
  • GFF 1959
  • Country
  • ADMA United States
  • GFF United States
  • Employees
  • ADMA N/A
  • GFF N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • GFF Building Products
  • Sector
  • ADMA Health Care
  • GFF Industrials
  • Exchange
  • ADMA Nasdaq
  • GFF Nasdaq
  • Market Cap
  • ADMA 3.7B
  • GFF 3.6B
  • IPO Year
  • ADMA N/A
  • GFF N/A
  • Fundamental
  • Price
  • ADMA $15.05
  • GFF $76.89
  • Analyst Decision
  • ADMA Strong Buy
  • GFF Strong Buy
  • Analyst Count
  • ADMA 3
  • GFF 4
  • Target Price
  • ADMA $27.67
  • GFF $99.00
  • AVG Volume (30 Days)
  • ADMA 3.1M
  • GFF 221.0K
  • Earning Date
  • ADMA 11-06-2025
  • GFF 11-12-2025
  • Dividend Yield
  • ADMA N/A
  • GFF 0.96%
  • EPS Growth
  • ADMA 469.09
  • GFF N/A
  • EPS
  • ADMA 0.85
  • GFF 1.49
  • Revenue
  • ADMA $474,174,000.00
  • GFF $2,517,417,000.00
  • Revenue This Year
  • ADMA $21.17
  • GFF N/A
  • Revenue Next Year
  • ADMA $26.03
  • GFF $2.03
  • P/E Ratio
  • ADMA $17.41
  • GFF $50.57
  • Revenue Growth
  • ADMA 43.58
  • GFF N/A
  • 52 Week Low
  • ADMA $13.50
  • GFF $62.26
  • 52 Week High
  • ADMA $25.67
  • GFF $86.73
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 47.74
  • GFF 52.64
  • Support Level
  • ADMA $14.35
  • GFF $74.35
  • Resistance Level
  • ADMA $15.60
  • GFF $76.18
  • Average True Range (ATR)
  • ADMA 0.52
  • GFF 1.89
  • MACD
  • ADMA 0.13
  • GFF 0.15
  • Stochastic Oscillator
  • ADMA 65.17
  • GFF 63.57

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About GFF Griffon Corporation

Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products: is a provider of branded consumer and professional tools; residential, industrial and commercial fans; home storage and organization products; and Home and Building Products conducts its operations through Clopay Corporation (Clopay). Clopay is the manufacturer and marketer of garage doors and rolling steel doors in North America. The company generates a majority of its revenue from the Home and Building Products segment. Operates in USA, Europe, Canada, Australia, and Others.

Share on Social Networks: